PFE SL-$25,72 TP-$26,08Technical Analysis:
MACD crossover on H4
Momentum
Mean reversion on the daily chart
Trade ideas
Swing trade with 15%+ upside potentialBased on RSI and price action, it seems that $25 is a good entry for a swing trade with TP at $29.50+, before next earnings report. The stock has done that move two times from December 2023. The only alarming factor is the sharp fall of OBV, but the risk-reward ratio of the play is very attractive.
Pfizer Is Little SickThe momentum to the downside is apparent here. This trade is setting up for a potential big move to the downside. The bullish trend that PFE had the last few weeks seems to just be a giant bear leg.
The chart above shows all the details. Momentum is in our favor here.
Pfizer will go to $ 5.05 and then maybe lowerThere is a beautiful Daily Chart bear flag playing out on this play. Plus , yes.
Pfizer, Inc (Wave analysis) - DailyPfizer, Inc (Wave analysis) - Daily
As shown in the chart, we are in downtrend wave 5 from A or 1
Regards.
Time to get out or.. to get in?The price reaches the bottom of the symmetrical compression triangle in which it has been moving for weeks.
A break downward brings the price back to the lows for a retest, while a possible (and I would say probable) rebound brings it back to the upper edge to attempt a breakout.
PFE looking higher with +10% profit potential PFE has finished strong correction and is finding a bottom near $25.
I anticipate that within the next three months, the stock, which I purchased at $26.5, will reach $30.
Blue line entry
Red stop
Green lines are target.
Pfizer Hoeless Than everPfizer is way hopeless than ever, unlike a Virus comes out just like Resident Evil and Pfizer comes to the rescue
But until then it's not worth looking after
PFE Trading IDEAThis could be setting up for a nice long term hold with yearly dividends of 6%
It is hated and ignored stock; it has had two huge volume downside weeks without much price progression to downside. It is a tell that it is being accumulated.
$PFE Wholesale Pfizer Inc. (PFE) is currently trading at wholesale levels between $24 and $26. In the retail market, its price ranges from $28 to $30, with key technical analysis suggesting a significant point at the golden ratio around the price level of $34
Breakout to either direction.PFE is currently trending sideways after its earnings report and election news. Personally I am long on Pfizer for 2025, but this doesn't mean the stock can't go lower. I am waiting on this move to either average down or hold.
PFE - Is There Any Value Here?After achieving the pinnacle of success during the Covid vaccine era, PFE has struggled to recover from falling vaccine sales. I had considered abandoning my core holdings but on further investigation, I liked what they were doing with their cancer drugs and continued to hold. A hefty dividend, albeit not supported much by earnings, continued also to be an attraction. The current washout with the nomination of Robert Kennedy Jr for a cabinet position could have been the last. AI generated pattern finder offers tempting long term gains.
Tempting opportunity for those with patience.
Pfizer Combo3 simple potential zones of influence I will be interested in if the price will start descending, for both types of scenarios: consolidations or complete reversals. Also interested in the green curve in case the price finds support there and doesn't look like it can penetrate decisively below after earnings report.
This is capitulation ! BUY now It is quite apparent that PFE and the vaccine space as a whole is witnessing capitulation. Details are explained in the video as to why a major bottom is forming.
After 20 years, $70
The promotion will be stomping on the meta for several years, then a $ 70 hike, it will be in 20 years.
$PFEGreen: Entry Point
Blue: Start of Week
Red: End of Week
Thumbs Up: Trade Available for Week
Numbers: Price Targets
*For share traders only. Not meant for options.
PFE LONG 1W After a huge decline in the share price, we can now see a bottoming pattern.
The fundamentals for the company seem decent, and it can be treated both long term investment and medium term trade.
My expectation is that the price will be range bound for longer, but my rules for this idea are:
- LONG position near the support line 26-27$.
- Take profit near the resistance around 31$
- Some fakeouts are possible, thus take profit either at price target, or at reversal visible on lower timeframes.
- stop loss once the price closes below 25$
PFE to take off soonNYSE:PFE Pfizer made a classic reversal and is now in retraction before next move up.
Is a long-mid time trade, anyway you will have around 6% dividends on your way as reward for waiting.
PFE chart update, Medicine is expensive So essentially, I tried to follow the trends.
When doing so, it does form an interesting pattern.
It almost looks like a long position chance.
It depends on where support lands with price action, and where the trend breakout occurs, as there is a nice gap setup on the charts that puts PFE on a climb and allows it to form a bullish long term trend.
Should trend break down past last support and confirm that underside exit, it would probably signal a bearish move is more likely.
However, It's a neat setup to watch.
good luck
Link to other PFE chart will be attached.
Pfizer chart is predicting bad news for the worldPfizer is showing signs of accumulation past few months which means a markup phase is coming very soon. I am assuming the market already knows some major catalyst is in the pipeline.
Pfizer BUY november 2024Long-term investment.
Macro Overview: Quality rules, the economy is trying to recover, but there's still too much uncertainty.
PFE Narrative:
Strong reports, yet the market reaction is muted. There's a deliberate offer to create negative sentiment, to prevent investors from believing in positive outcomes.
Thoughts:
Buy now. Current price $28.09
! NOT A RECOMMENDATION !
Q3 Trade PfizerQ3 results for Pfizer were solid, with adjusted earnings and revenue surpassing expectations. The current drop in share price seems excessive and may be driven by liquidity concerns rather than underlying performance issues. The significant decline in expected sales for COVID products is concerning, but overall, the fundamentals appear stable. This drop could present a buying opportunity if it’s mainly a liquidity grab
